In a 32‑year‑old man with myalgias, leukocytosis and neutrophilia, does a normal creatine kinase (CK) exclude inflammatory muscle disease, and what further evaluation should be pursued?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal CK Does NOT Exclude Inflammatory Muscle Disease

A normal creatine kinase (CK) level does not exclude inflammatory muscle disease in this patient with myalgias and leukocytosis, and further evaluation with aldolase, inflammatory markers, MRI, and potentially muscle biopsy is essential.

Why Normal CK Can Be Misleading

While CK is the most commonly used biomarker for muscle inflammation, multiple inflammatory myopathies can present with normal CK levels 1, 2. The ASCO guidelines explicitly recognize that other muscle enzymes including aldolase, transaminases (AST, ALT), and LDH can be elevated even when CK is normal 1. Recent case series demonstrate that dermatomyositis, overlap myositis, and immune-mediated myopathies can all present with isolated aldolase elevation and normal CK 3.

Key clinical distinction: Muscle weakness is more typical of myositis than pain alone 1, 2. However, the presence of leukocytosis and neutrophilia in this patient raises concern for systemic inflammation that warrants thorough investigation.

Immediate Diagnostic Workup Required

Blood Testing (Priority Order)

  1. Aldolase - Can be elevated when CK is normal in up to 50% of certain myopathies 3
  2. Transaminases (AST, ALT) and LDH - Alternative markers of muscle inflammation 1
  3. Troponin - Essential to evaluate for myocardial involvement, which can be life-threatening 1, 2
  4. Inflammatory markers (ESR, CRP) - Already showing leukocytosis; quantify inflammation 1
  5. Myositis-specific antibodies - Including anti-Jo-1 and other myositis panel 1, 2
  6. Anti-AChR and antistriational antibodies - To evaluate for concomitant myasthenia gravis 2

Clinical Examination Focus

  • Assess muscle strength systematically: Proximal upper and lower extremities, neck flexors vs extensors 1, 4
  • Examine skin carefully: Look for heliotrope rash, Gottron's papules/sign suggesting dermatomyositis 1, 4
  • Evaluate for bulbar symptoms: Dysphagia, dysarthria, dysphonia indicating severe disease 5
  • Cardiac symptoms: Dyspnea, palpitations, chest pain suggesting myocarditis 2, 5

Advanced Imaging and Testing

If initial blood work shows elevated aldolase or other muscle enzymes, or if clinical suspicion remains high:

  • MRI of proximal limbs - Can demonstrate muscle edema and inflammation even with normal CK 1, 2, 6, 7, 8
  • EMG - Consider when diagnosis uncertain or neurologic overlap suspected 1
  • Muscle biopsy - Definitive when diagnosis uncertain; essential for detecting perimysial pathology, vasculitis, or specific inflammatory patterns 1, 9, 6, 3

Critical Differential Diagnoses to Consider

Given normal CK with myalgias and systemic inflammation:

  1. Isolated muscle vasculitis - Can present without CK elevation but with marked inflammatory markers 6
  2. Dermatomyositis with normal CK - Features higher ESR, less cutaneous involvement, and perifascicular mitochondrial pathology 3
  3. Viral myositis - Can occur with normal CK but elevated inflammatory markers 7
  4. Muscular polyarteritis nodosa - Normal CK and EMG can delay diagnosis 9

When to Escalate Care

Refer urgently to rheumatology or neurology if:

  • Any elevation in aldolase or other muscle enzymes
  • Objective muscle weakness on examination
  • Cardiac symptoms or troponin elevation
  • Systemic symptoms with high inflammatory markers persist

The 2021 EULAR guidelines emphasize that CK levels are usually within normal range in patients presenting with myalgia alone 5, but this does not exclude serious inflammatory muscle disease, particularly when systemic inflammation is present.

Common Pitfall

The most dangerous error is dismissing inflammatory myopathy based solely on normal CK. Approximately 50% of certain myopathies with perimysial pathology present with isolated aldolase elevation 3. Missing early inflammatory myopathy—particularly if myocarditis is present—can be fatal, with mortality rates around 20% in checkpoint inhibitor-related myositis compared to <10% in idiopathic forms 5.

References

Research

Asymmetrical muscular disorder with normal creatine kinase (CK) and electromyography (EMG): the challenging diagnosis of muscular polyarteritis nodosa (MPAN), case report and literature review.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026

Related Questions

In a 32-year-old man with myalgias, leukocytosis, neutrophilia, and normal creatine kinase, does a normal erythrocyte sedimentation rate exclude inflammatory myopathy?
What are the differential diagnoses for a young adult with a two‑month history of burning pain in the lower limbs, creatine kinase around 2000 U/L, normal lower‑limb MRI and normal electromyography, anesthesia, neuropathic‑type pain syndrome, prior obesity now losing weight, currently receiving vitamin B12 supplementation, and who has discontinued metformin (Glifage) and a weight‑loss medication (Lipolass) with partial symptom improvement?
In a 48-year-old man with chronic generalized muscle pain (predominantly posterior trunk), normal spinal MRI, normal creatine kinase, normal thyroid and renal function, elevated triglycerides, positive antinuclear antibody, dry eyes and occasional dry mouth, sleep disturbance and fatigue that worsen after viral infection or long‑haul flights, what is the most likely diagnosis and what are the key differential diagnoses?
How should I evaluate and manage a patient with neuropathic electromyography (EMG) findings, elevated creatine kinase (CK), and muscle cramps?
Given a mildly elevated creatine kinase (CK) level, normal ferritin, a positive antinuclear antibody (ANA) screen driven by high anti‑RNP antibodies, a negative extractable nuclear antigen (ENA) panel, and otherwise normal CBC, CMP, folate, liver and kidney function tests while awaiting C‑reactive protein (CRP), homocysteine, and erythrocyte sedimentation rate (ESR) results, what is the likely significance and what are the recommended next steps?
In a man with hemoglobin 16.4 g/dL, hematocrit 49%, normal platelet count, normal mean corpuscular volume, and spleen size 13.5 cm, what is the appropriate workup and management?
How should I manage a 32-year-old male presenting with myalgias, serum albumin 5.2 g/dL, leukocytosis (WBC 12.7 ×10⁹/L), and neutrophilia (absolute neutrophil count 10,668/µL)?
Does spinal cord stimulation treat neuropathic pain?
In a 32-year-old man with myalgias, leukocytosis, neutrophilia, and normal creatine kinase, does a normal erythrocyte sedimentation rate exclude inflammatory myopathy?
To which specialist should I refer a patient with suspected inflammatory myopathy presenting with leukocytosis, neutrophilia, and muscle weakness?
Should a 70-year-old male with a history of iron-deficiency anemia and gastric bypass, who now has a low hemoglobin (12.7 g/dL) and hematocrit (38.2 %) but normal ferritin and serum iron, continue iron supplementation, and when should his labs be rechecked?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.